ARTLVSGTBP• 6 Months (Normalized)
ARTL vs GTBP (Artelo Biosciences Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
GTBP Performance $6.88
+1444.94%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1444.94 pts
GTBP outperforming by 1444.94 percentage points
ARTLGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | ARTL Price | ARTL Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $6.88 | +1444.94% | - | |
| Sep 28, 2026 | $- | $6.80 | +1428.09% | - | |
| Sep 25, 2026 | $4.54 | -92.37% | $6.89 | +1448.31% | -1540.68% |
| Sep 24, 2026 | $5.17 | -91.31% | $6.83 | +1434.83% | -1526.14% |
| Sep 23, 2026 | $7.31 | -87.71% | $7.10 | +1495.51% | -1583.22% |
| Sep 22, 2026 | $4.15 | -93.02% | $- | - | |
| Sep 21, 2026 | $4.10 | -93.11% | $7.18 | +1513.48% | -1606.59% |
| Sep 18, 2026 | $3.94 | -93.38% | $7.16 | +1508.99% | -1602.37% |
| Sep 17, 2026 | $3.97 | -93.33% | $7.49 | +1583.15% | -1676.48% |
| Sep 16, 2026 | $3.75 | -93.70% | $7.81 | +1655.06% | -1748.76% |
| Sep 15, 2026 | $5.34 | -91.02% | $9.00 | +1922.47% | -2013.49% |
| Sep 14, 2026 | $4.87 | -91.81% | $11.63 | +2513.48% | -2605.29% |
| Sep 11, 2026 | $5.43 | -90.87% | $8.61 | +1834.83% | -1925.70% |
| Sep 10, 2026 | $5.63 | -90.54% | $6.18 | +1288.76% | -1379.30% |
| Sep 09, 2026 | $5.98 | -89.95% | $5.98 | +1243.82% | -1333.77% |
Page 1 of 9